Cited 0 time in
Akt-isoform specific inhibition of MDA-MB-231 Cell Proliferation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 신인철 | - |
| dc.date.accessioned | 2021-08-03T21:34:35Z | - |
| dc.date.available | 2021-08-03T21:34:35Z | - |
| dc.date.issued | 2009-07-08 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/61317 | - |
| dc.description.abstract | To dissect the isoform-specific rolesAkt in breast cancer cells, constitutively active Akt isoforms were introduced into MDA-MB-231 cells. Both Akt1 and Akt2 efficiently inhibited the growth of MDA-MB-231 cells. Over-expression of Akt1 down-regulated ERK activity by inhibiting Ser 259 phosphorylation of c-Rafand subsequentdownstream signaling. Akt2 over-expression up-regulated the cell cycle inhibitor p27. Cycloheximide decay assaysthat Akt2 increased the stability and nuclear localization of p27, thus inhibiting the cyclin E-CDK2 complex. These resultssuggest that the inhibition of cell proliferation by Akt1 and Akt2 is mediated by isoform-specific mechanisms. | - |
| dc.title | Akt-isoform specific inhibition of MDA-MB-231 Cell Proliferation | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | Beatson International Cancer Conference | - |
| dc.citation.conferencePlace | 영국 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
